Biological E

Hyderabad set to emerge as global hub for COVID-19 vaccine in 2021

The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing.

published on : 27th December 2020

Over 60 foreign envoys to be taken to leading pharma companies in Hyderabad on Wednesday

Official sources said the visit of the foreign heads of missions in India to Hyderabad is being organised as part of MEA's COVID-19 briefing initiative.

published on : 8th December 2020

Indigenous vaccine developed by Hyderabad-based Biological E gets nod for human trial

This is the fifth potential Covid-19 vaccine permitted for clinical trial in India, days after Dr Reddy’s Laboratories. received a go-ahead to carry out phase 2 and 3 trials in the country.

published on : 29th October 2020

Vaccine race: Hyderabad-based Biological E Limited ties up with Janssen

As part of the said agreement, J&J will be transferring the manufacturing technology to Biological E. Johnson & Johnson’s vaccine (Ad26.COV2) is currently in the Phase 1/2a of clinical trials

published on : 14th August 2020

Set up an institute in the South for faster clearances, say pharma majors

Pharma companies demanded a branch of Central Drugs Standard Control Organisation at Hyderabad for South India.

published on : 5th August 2020

Seven Indian pharma players race to develop COVID-19 vaccine

Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end.

published on : 19th July 2020